Clinician review checklist

Peptide therapy medical history review: what should your clinician ask?

Prepare for online peptide therapy with a clinician-safe medical history checklist covering goals, diagnoses, medications, allergies, labs, pregnancy questions, product-specific risks, pharmacy labels, follow-up, and seller red flags.

Educational guideUpdated May 15, 2026

What belongs in the review?

1

Start with the goal and symptom context, not a peptide menu or prebuilt stack.

2

List diagnoses, surgeries, pregnancy or fertility context, allergies, prior side effects, and recent urgent symptoms.

3

Share every prescription, over-the-counter medicine, supplement, stimulant, hormone product, and nootropic being used.

4

Match the history to the product: GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu topical, and methylene blue raise different safety questions.

5

Confirm pharmacy source, labels, follow-up, refill review, and red flags before paying or starting care.

Direct answer

A peptide therapy medical history review should cover your goals, diagnoses, medications, supplements, allergies, prior side effects, recent labs or vitals when relevant, pregnancy context, and product-specific risks before any prescription decision. The clinician may approve, decline, delay, request records, or redirect care based on safety and fit.

Before product selection

The review should connect your goal to your health context

A safer online intake should ask why you are seeking care, what has already been tried, what diagnoses or symptoms are active, and whether the concern needs local or specialist evaluation before peptide-related treatment. Weight loss, energy, sleep, recovery, skin, hair, sexual health, and longevity goals do not use the same screening checklist.

  • Expect questions about current diagnoses, recent hospitalizations, surgeries or procedures, pregnancy or breastfeeding context, cancer history, heart, kidney, liver, thyroid, mental-health, and eating-disorder history when relevant.
  • Share baseline information such as weight, blood pressure, glucose or A1C, lipid labs, kidney or liver labs, skin photos, or symptom notes only when the clinician asks for them for the specific product being considered.
  • A clinician should be able to say no, pause the request, ask for records, or recommend local care when the online setting does not fit the risk profile.

Medication reconciliation

Every medication and supplement can change the safety conversation

Medication history is not a formality. GLP-1s can overlap with diabetes medicines and gastrointestinal symptoms; PT-141/bremelanotide raises blood-pressure questions; methylene blue requires serotonin-medication and G6PD review; sermorelin may involve growth-hormone-axis and lab context; topical products can interact with irritated skin or active skincare routines.

  • Include prescription drugs, over-the-counter medicines, vitamins, minerals, herbs, sleep aids, stimulants, protein or creatine products, hormone products, nootropics, and recent antibiotics, antivirals, antifungals, or steroids.
  • Share allergies, asthma or sulfite sensitivity, prior injection-site reactions, rash or irritation with topical products, nausea or dehydration history, and any previous adverse reaction to a similar medication.
  • Do not stop, start, split, restart, or combine medications based on online forums, seller charts, or supplement-stack advice; use the history review to ask the clinician what is safe for your case.

After review

A good history review continues into follow-up and pharmacy checks

The review should lead to clear next steps: whether more records are needed, which product status applies, what pharmacy or manufacturer pathway may be used if prescribed, how labels and storage will be checked, how side effects are reported, and what needs reassessment before refills or product changes.

  • Ask whether the proposed product is FDA-approved for the discussed use, an individualized compounded prescription, an off-label use, a topical cosmetic-style product, or not appropriate based on the information provided.
  • Confirm that pharmacy labels include the active ingredient, route, strength or concentration when relevant, storage directions, beyond-use or expiration date, prescriber instructions, and contact paths for pharmacy questions.
  • Avoid no-prescription checkout, research-use vials for human use, guaranteed approval, generic peptide stacks, copied dose charts, hidden pharmacy sourcing, or claims that compounded finished medications are FDA-approved.

Patient safety checklist

Medical history details to gather before online peptide therapy

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

Primary goal, symptom timeline, prior treatments, and what would count as benefit, no benefit, or a reason to stop.

Current diagnoses, surgeries or procedures, urgent symptoms, and whether a primary-care or specialist clinician is already involved.

Complete medication list, including prescriptions, OTC medicines, supplements, hormones, stimulants, sleep aids, nootropics, and recent short-term medicines.

Allergies, asthma, sulfite sensitivity, skin irritation history, prior injection reactions, nausea or dehydration problems, and any previous medication side effects.

Pregnancy, breastfeeding, fertility treatment, contraception, perimenopause or menopause context, or plans to become pregnant when relevant.

Vitals, labs, pharmacy labels, outside records, photos, wearable trends, or prior clinic notes the clinician requests for the specific product.

Product-specific questions for GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu topical products, methylene blue, or branded versus compounded options.

Follow-up plan for side effects, refills, dose-change questions, shipment or storage issues, urgent symptoms, local care, and pharmacy communication.

FAQs

Short answers for patients

Why does an online peptide clinician need my medical history?

Medical history helps the clinician decide whether a product is appropriate, whether records or labs are needed, whether another type of care is safer, and what risks or interactions need review before prescribing.

What if I do not have recent labs or records?

That does not automatically mean approval or denial. Lab and record needs depend on the goal, product, symptoms, health history, medications, and clinician judgment. Some requests can move forward with available information; others should wait for records or local evaluation.

Should I mention supplements and nootropics?

Yes. Supplements, nootropics, herbs, minerals, protein products, creatine, sleep aids, stimulants, and hormone products can overlap with side effects, lab interpretation, medication risks, or product-quality questions.

Can a clinician decline peptide therapy after reviewing my history?

Yes. A responsible clinician may decline, delay, request more information, change the product under consideration, or refer you to local or specialist care when the history suggests the online option is not the safest fit.

Are compounded peptide medications FDA-approved?

Compounded finished medications are not FDA-approved in the same way as branded drug products. They may be prescribed for an individual patient when clinically appropriate and legally available, but clinician review and pharmacy quality remain important.

What are red flags during a medical history review?

Be cautious of no-prescription checkout, guaranteed approval, sellers that do not ask about medications or diagnoses, research-use products for human use, copied dosing charts, hidden pharmacy sourcing, and pressure to buy generic peptide stacks.